Fig 1: Biodistribution of AuNPs with control (PBS), IL-2, IL-6, and IL-21 treatment. (A) Schematic illustration of the MC38 mouse tumor model with the control, IL-2, IL-6, and IL-21 treatment, and AuNPs treatment. (B) Au-content in the liver, spleen, kidney, and tumor by ICP-MS (n = 4 or 5). Data presented as the mean ± S. E. M.
Fig 2: Physiological index with control (PBS), IL-2, IL-6, and IL-21 treatment. (A) Body weight changes of the mice treated with the control, IL-2, IL-6, and IL-21 as per Fig. 3A (n = 5). Data presented as the mean ± S. E. M. (B) Organ weight of mice treated with the control, IL-2, IL-6, and IL-21 (n = 5). Data presented as the mean ± S. E. M. (C) Histology of the liver, spleen, and kidney of the mice treated with control, IL-2, IL-6, and IL-21 (n = 5).
Supplier Page from MedChemExpress for IL-21 Protein, Mouse (129a.a)